Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127410471 | 12741047 | 1 | I | 20100621 | 20110607 | 20160914 | 20160914 | EXP | US-ROCHE-783254 | ROCHE | 79.97 | YR | M | Y | 76.70000 | KG | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127410471 | 12741047 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | CYCLE 28 DAYS; OVER 30-90 MINUTES ON DAYS 1 AND 15; PATIENT WAS OFF STUDY SINCE 06 JULY 2010?LAST TR | 125085 | 1536 | MG | ||||||||
| 127410471 | 12741047 | 2 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | CYCLE 28 DAYS; ON DAYS 1, 8, 15, 22; PATIENT WAS OFF STUDY SINCE 06 JULY 2010.?LAST TREATMENT RECEIV | 0 | 75 | MG | ||||||||
| 127410471 | 12741047 | 3 | SS | MEGESTROL ACETATE. | MEGESTROL ACETATE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127410471 | 12741047 | 1 | Pancreatic neoplasm |
| 127410471 | 12741047 | 2 | Pancreatic neoplasm |
| 127410471 | 12741047 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127410471 | 12741047 | LT |
| 127410471 | 12741047 | HO |
| 127410471 | 12741047 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127410471 | 12741047 | Dyspnoea | |
| 127410471 | 12741047 | Fatigue | |
| 127410471 | 12741047 | Hyperglycaemia | |
| 127410471 | 12741047 | Left ventricular dysfunction | |
| 127410471 | 12741047 | Muscular weakness | |
| 127410471 | 12741047 | Oedema peripheral | |
| 127410471 | 12741047 | Pleural effusion | |
| 127410471 | 12741047 | Pulmonary haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127410471 | 12741047 | 1 | 20100525 | 20100608 | 0 |